{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:41:51Z","timestamp":1793090511456,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpddr.2026.100672","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:20:48Z","timestamp":1790781648000},"page":"100672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A rapid sporozoite viability assay identifies leads and targetable enzymatic activities against the zoonotic Cryptosporidium parvum"],"prefix":"10.1016","volume":"32","author":[{"given":"Peng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0659","authenticated-orcid":false,"given":"Guan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2026.100672_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.mcb.2025.03.015","article-title":"High-throughput cell viability assessment using a luminescent ATP detection assay","volume":"204","author":"Alawieh","year":"2026","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib2","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.40.11.2468","article-title":"Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactions","volume":"40","author":"Alexov","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100672_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/978-1-0716-4824-7_22","article-title":"Cryptosporidium oocyst purification using discontinuous gradient centrifugation","volume":"2978","author":"Arrowood","year":"2026","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib4","doi-asserted-by":"crossref","first-page":"89S","DOI":"10.1111\/j.1550-7408.1996.tb05015.x","article-title":"Improved purification methods for calf-derived Cryptosporidium parvum oocysts using discontinuous sucrose and cesium chloride gradients","volume":"43","author":"Arrowood","year":"1996","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib5","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/AAC.02460-12","article-title":"Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth","volume":"57","author":"Bessoff","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2026.100672_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200215","article-title":"Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: insights into health aspects","volume":"355","author":"Brtko","year":"2022","journal-title":"Arch. Pharm. (Weinheim, Ger.)"},{"key":"10.1016\/j.ijpddr.2026.100672_bib7","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41564-026-02331-5","article-title":"Genomic heterogeneity of NAD(P)H dehydrogenase predisposes Cryptosporidium to clofazimine resistance","volume":"11","author":"Buenconsejo","year":"2026","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib8","doi-asserted-by":"crossref","first-page":"244S","DOI":"10.1177\/1091581810385956","article-title":"Final report of the safety assessment of kojic acid as used in cosmetics","volume":"29","author":"Burnett","year":"2010","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","article-title":"A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium","volume":"15","author":"Checkley","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100672_bib10","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1021\/bi400177y","article-title":"Kinetic characterization of hydrolysis of nitrocefin, cefoxitin, and meropenem by beta-lactamase from Mycobacterium tuberculosis","volume":"52","author":"Chow","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpddr.2026.100672_bib11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/antibiotics14121189","article-title":"Current advances in developing new antimicrobial agents against non-tuberculous Mycobacterium","volume":"14","author":"Cross","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijpddr.2026.100672_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90719-0","article-title":"Insights of antiparasitic activity of sodium diethyldithiocarbamate against different strains of Trypanosoma cruzi","volume":"11","author":"de Freitas Oliveira","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2026.100672_bib13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0020-7519(99)00076-4","article-title":"A review of the importance of cryptosporidiosis in farm animals","volume":"29","author":"de Graaf","year":"1999","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48723-y","article-title":"Human metallo-beta-lactamase enzymes degrade penicillin","volume":"9","author":"Diene","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2026.100672_bib15","doi-asserted-by":"crossref","first-page":"10263","DOI":"10.1021\/acs.jmedchem.4c00597","article-title":"Colloidal aggregation confounds cell-based Covid-19 antiviral screens","volume":"67","author":"Glenn","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2026.100672_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ab.2005.04.035","article-title":"The five-parameter logistic: a characterization and comparison with the four-parameter logistic","volume":"343","author":"Gottschalk","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijpddr.2026.100672_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-0716-0635-3_18","article-title":"Luminescence-based, Low- and medium-throughput assays for drug screening in Schistosoma mansoni larval stage","volume":"2151","author":"Guidi","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/infdis\/jix689","article-title":"The existing drug vorinostat as a new lead against cryptosporidiosis by targeting the parasite histone deacetylases","volume":"217","author":"Guo","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100672_bib19","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3390\/microorganisms10122456","article-title":"Cryptosporidiosis: from prevention to treatment, a narrative review","volume":"10","author":"Helmy","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijpddr.2026.100672_bib20","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/acsinfecdis.0c00803","article-title":"Pyrrolopyrimidine bumped kinase inhibitors for the treatment of cryptosporidiosis","volume":"7","author":"Hulverson","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100672_bib21","series-title":"Assay Guidance Manual","article-title":"HTS assay validation","author":"Iversen","year":"2012"},{"key":"10.1016\/j.ijpddr.2026.100672_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1087057105285610","article-title":"A comparison of assay performance measures in screening assays: signal window, Z' factor, and assay variability ratio","volume":"11","author":"Iversen","year":"2006","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ijpddr.2026.100672_bib23","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3389\/fmicb.2019.01999","article-title":"Discovery of novel anti-cryptosporidial activities from natural products by in vitro high-throughput phenotypic screening","volume":"10","author":"Jin","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib24","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/s41467-019-09880-w","article-title":"A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors","volume":"10","author":"Jumani","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2026.100672_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1115522","article-title":"Past, current, and potential treatments for cryptosporidiosis in humans and farm animals: a comprehensive review","volume":"13","author":"Khan","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib26","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2026.100672_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jac\/dkh080","article-title":"In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain","volume":"53","author":"Ko","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2026.100672_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2026.100672_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/bios12040196","article-title":"Revisiting the resazurin-based sensing of cellular viability: widening the application horizon","volume":"12","author":"Lavogina","year":"2022","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.ijpddr.2026.100672_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012881","article-title":"Targeting translation initiation yields fast-killing therapeutics against the zoonotic parasite Cryptosporidium parvum","volume":"21","author":"Li","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2026.100672_bib31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13071-022-05286-8","article-title":"The mucin-like, secretory type-I transmembrane glycoprotein GP900 in the apicomplexan Cryptosporidium parvum is cleaved in the secretory pathway and likely plays a lubrication role","volume":"15","author":"Li","year":"2022","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpddr.2026.100672_bib32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejmech.2018.04.006","article-title":"Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation","volume":"151","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2026.100672_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005373","article-title":"A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis","volume":"11","author":"Love","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2026.100672_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/acsinfecdis.6b00094","article-title":"Cryptosporidiosis drug discovery: opportunities and challenges","volume":"2","author":"Manjunatha","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100672_bib35","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1038\/s41564-024-01810-x","article-title":"Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat paediatric enteric cryptosporidiosis","volume":"9","author":"Manjunatha","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature22337","article-title":"A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis","volume":"546","author":"Manjunatha","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2026.100672_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.enz.2024.06.001","article-title":"Drug design of tyrosinase inhibitors","volume":"56","author":"Melfi","year":"2024","journal-title":"Enzymes"},{"key":"10.1016\/j.ijpddr.2026.100672_bib38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pt.2004.01.015","article-title":"Update on Cryptosporidium and Giardia infections in cattle","volume":"20","author":"Olson","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib39","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3324\/haematol.2016.154377","article-title":"Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in Non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study","volume":"102","author":"Ribrag","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.ijpddr.2026.100672_bib40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijpara.2008.11.012","article-title":"An apicomplexan ankyrin-repeat histone deacetylase with relatives in photosynthetic eukaryotes","volume":"39","author":"Rider","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib41","article-title":"Study of the economic impact of cryptosporidiosis in calves after implementing good practices to manage the disease on dairy farms in Belgium, France, and the Netherlands","volume":"4","author":"Roblin","year":"2023","journal-title":"Curr Res Parasitol Vector Borne Dis"},{"key":"10.1016\/j.ijpddr.2026.100672_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.exppara.2009.07.005","article-title":"Cryptosporidium and Giardia: treatment options and prospects for new drugs","volume":"124","author":"Rossignol","year":"2010","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/321008","article-title":"Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide","volume":"184","author":"Rossignol","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100672_bib44","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ijpara.2021.08.007","article-title":"Taxonomy and molecular epidemiology of Cryptosporidium and Giardia - a 50 year perspective (1971-2021)","volume":"51","author":"Ryan","year":"2021","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib45","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/pmic.200700804","article-title":"Determining the protein repertoire of Cryptosporidium parvum sporozoites","volume":"8","author":"Sanderson","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.ijpddr.2026.100672_bib46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijpara.2020.03.002","article-title":"Long-term production effects of clinical cryptosporidiosis in neonatal calves","volume":"50","author":"Shaw","year":"2020","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7243\/2049-7962-2-21","article-title":"PCI-24781 (abexinostat), a novel histone deacetylase inhibitor, induces reactive oxygen species-dependent apoptosis and is synergistic with bortezomib in neuroblastoma","volume":"2","author":"Sholler","year":"2013","journal-title":"J. Cancer Therapeut. Res."},{"key":"10.1016\/j.ijpddr.2026.100672_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/108705719700200306","article-title":"Design of signal windows in high throughput screening assays for drug discovery","volume":"2","author":"Sittampalam","year":"1997","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.ijpddr.2026.100672_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-8278(02)00384-7","article-title":"Selective blockade of mGlu5 metabotropic glutamate receptors is protective against acetaminophen hepatotoxicity in mice","volume":"38","author":"Storto","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiag246","article-title":"Development of a phase 1 cryptosporidiosis controlled human challenge model in healthy volunteers using current good manufacturing practice Cryptosporidium Parvum oocysts and conducted under an investigational new drug application","author":"Stuart","year":"2026","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2026.100672_bib51","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/ph15040470","article-title":"Antiplasmodial activity of Vachellia xanthophloea (Benth.) P.J.H. hurter (African fever tree) and its constituents","volume":"15","author":"Tajuddeen","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpddr.2026.100672_bib52","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/s41564-019-0539-x","article-title":"Life cycle progression and sexual development of the apicomplexan parasite Cryptosporidium parvum","volume":"4","author":"Tandel","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.imbio.2008.11.015","article-title":"Dynamics of gut mucosal and systemic Th1\/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection","volume":"214","author":"Tessema","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijpddr.2026.100672_bib54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/vr.d1492","article-title":"Efficacy of halofuginone lactate in the prevention of cryptosporidiosis in dairy calves","volume":"168","author":"Trotz-Williams","year":"2011","journal-title":"Vet. Rec."},{"key":"10.1016\/j.ijpddr.2026.100672_bib55","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ijpara.2006.02.023","article-title":"Quantitative and qualitative comparisons of cryptosporidium faecal purification procedures for the isolation of oocysts suitable for proteomic analysis","volume":"36","author":"Truong","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.pbb.2012.09.016","article-title":"Interactions of CB1 and mGlu5 receptor antagonists in food intake, anxiety and memory models in rats","volume":"103","author":"Varga","year":"2012","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.ijpddr.2026.100672_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0022-3565(24)34881-5","article-title":"SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5","volume":"290","author":"Varney","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ijpddr.2026.100672_bib58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature14651","article-title":"Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum","volume":"523","author":"Vinayak","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2026.100672_bib59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-0716-4824-7_18","article-title":"Phenotypic high-throughput screening and drug efficacy test against the growth of Cryptosporidium parvum in vitro by qRT-PCR","volume":"2978","author":"Wang","year":"2026","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03158-23","article-title":"Requirement of microtubules for secretion of a micronemal protein CpTSP4 in the invasive stage of the apicomplexan Cryptosporidium parvum","volume":"15","author":"Wang","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.ijpddr.2026.100672_bib61","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s13071-026-07538-3","article-title":"A comprehensive proteome and the first phosphoproteome reveal extensive phosphorylation of carbohydrate metabolism in Cryptosporidium parvum sporozoites","volume":"19","author":"Wang","year":"2026","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpddr.2026.100672_bib62","doi-asserted-by":"crossref","first-page":"e00115-20","DOI":"10.1128\/CMR.00115-20","article-title":"New beta-lactam-beta-lactamase inhibitor combinations","volume":"34","author":"Yahav","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2026.100672_bib63","first-page":"125","article-title":"Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani","volume":"10","author":"Zahid","year":"2019","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2026.100672_bib64","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3389\/fmicb.2015.00991","article-title":"Quantitative RT-PCR assay for high-throughput screening (HTS) of drugs against the growth of Cryptosporidium parvum in vitro","volume":"6","author":"Zhang","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib65","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-1-4939-9748-0_18","article-title":"High-throughput screening of drugs against the growth of Cryptosporidium parvum in vitro by qRT-PCR","volume":"2052","author":"Zhang","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpddr.2026.100672_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ijpddr.2026.100672_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2025.2597642","article-title":"Pathogenicity and virulence of Cryptosporidium","volume":"16","author":"Zhang","year":"2025","journal-title":"Virulence"},{"key":"10.1016\/j.ijpddr.2026.100672_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2026.2707806","article-title":"Cryptosporidium parvum CpARO marks rhoptry envelope remnants associated with feeder organelle formation","volume":"17","author":"Zhang","year":"2026","journal-title":"Virulence"},{"key":"10.1016\/j.ijpddr.2026.100672_bib69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s44149-021-00002-y","article-title":"Current status and challenges in drug discovery against the globally important zoonotic cryptosporidiosis","volume":"1","author":"Zhu","year":"2021","journal-title":"Animal Dis."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320726000424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320726000424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:16:03Z","timestamp":1793088963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320726000424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":69,"alternative-id":["S2211320726000424"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2026.100672","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rapid sporozoite viability assay identifies leads and targetable enzymatic activities against the zoonotic Cryptosporidium parvum","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2026.100672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100672"}}